Spago Nanomedical begins endometriosis study
Clinical trial has received regulatory approval and involves endometriosis candidate SN132D
Spago Nanomedical begins endometriosis study
Clinical trial has received regulatory approval and involves endometriosis candidate SN132D
LEO Pharma reveal positive results from delgocitinib research
Phase 3 clinical trial focuses on adults with moderate-to-severe chronic hand eczema
Odimma Therapeutics and Touchlight announce clinical material collaboration
Partnership aims to progress personalised cancer therapy by incorporating doggybone DNA
AstraZeneca focuses on breast cancer care transformation
Data reinforces potential to deliver new standards across HER2-targetable breast cancer
ONWARD reveals ARC therapy spinal cord injury report
Implantable ARC therapy demonstrates potential to improve blood pressure regulation
Laevoroc announces promising purine nucleoside phosphorylase data
Data supports LR 09 as a vital checkpoint inhibitor for treating leukaemia patients
Contact
c o n n e c t
We help you make confident decisions based on data
Phone Number
+33 (0) 139 141 301
Address
16 Rue Washington, 75008 Paris